These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1374546)

  • 41. The limitation of IL-10-exposed dendritic cells in the treatment of experimental autoimmune myasthenia gravis and myasthenia gravis.
    Xiao BG; Duan RS; Zhu WH; Lu CZ
    Cell Immunol; 2006 Jun; 241(2):95-101. PubMed ID: 17005165
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Natural autoantibodies, IgG antibodies to tetanus toxoid and CD5+ B cells in patients with Mediterranean visceral leishmaniasis. The Leishmania Study Group.
    Louzir H; Belal-Kacemi L; Sassi A; Laouini D; Ben Ismail R; Dellagi K
    Clin Exp Immunol; 1994 Mar; 95(3):479-84. PubMed ID: 7511080
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased peripheral blood B-cells expressing the CD5 molecules in association to autoantibodies in patients with lupus erythematosus and evidence to selectively down-modulate them.
    Böhm I
    Biomed Pharmacother; 2004 Jun; 58(5):338-43. PubMed ID: 15194170
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessment of cellular and humoral immunity of myasthenics.
    Huang SW; Rose JW; Mayer RF
    J Neurol Neurosurg Psychiatry; 1977 Nov; 40(11):1053-9. PubMed ID: 304474
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CD19+ Tim-1+ B cells are decreased and negatively correlated with disease severity in Myasthenia Gravis patients.
    Zhang Y; Zhang X; Xia Y; Jia X; Li H; Zhang Y; Shao Z; Xin N; Guo M; Chen J; Zheng S; Wang Y; Fu L; Xiao C; Geng D; Liu Y; Cui G; Dong R; Huang X; Yu T
    Immunol Res; 2016 Dec; 64(5-6):1216-1224. PubMed ID: 27677768
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value.
    Lindstrom JM; Seybold ME; Lennon VA; Whittingham S; Duane DD
    Neurology; 1976 Nov; 26(11):1054-9. PubMed ID: 988512
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clonotypic analysis of anti-acetylcholine receptor antibodies from experimental autoimmune myasthenia gravis-sensitive Lewis rats and experimental autoimmune myasthenia gravis-resistant Wistar Furth rats.
    Zoda T; Yeh TM; Krolick KA
    J Immunol; 1991 Jan; 146(2):663-70. PubMed ID: 1987281
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CD5 expression on B cells may be an activation marker for secretion of anti-myelin antibodies in patients with polyneuropathy associated with monoclonal gammopathy.
    Ekerfelt C; Ernerudh J; Solders G; Vrethem M
    Clin Exp Immunol; 1995 Aug; 101(2):346-50. PubMed ID: 7544252
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Heterogeneity of immunopathological features of AChR/MuSK autoantibody-negative myasthenia gravis.
    Hayashi A; Shiono H; Ohta M; Ohta K; Okumura M; Sawa Y
    J Neuroimmunol; 2007 Sep; 189(1-2):163-8. PubMed ID: 17706794
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Paraneoplastic IgG striational autoantibodies produced by clonal thymic B cells and in serum of patients with myasthenia gravis and thymoma react with titin.
    Williams CL; Hay JE; Huiatt TW; Lennon VA
    Lab Invest; 1992 Mar; 66(3):331-6. PubMed ID: 1538587
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CD5+ B cells predominate in peripheral tissues of rabbit.
    Raman C; Knight KL
    J Immunol; 1992 Dec; 149(12):3858-64. PubMed ID: 1281192
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Distribution of B-lymphocyte subgroup CD20 and its clinical significance in patients with myasthenia gravis].
    Zhang Q; Hu Y; Zhang L; Li Y; Yin H; Li J
    Zhonghua Wai Ke Za Zhi; 1998 Apr; 36(4):239-41. PubMed ID: 11825378
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro T-cell dependent B-cell activity in myasthenia gravis.
    Limburg PC; Hummel-Tappel E; Oosterhuis HJ; The TH
    Clin Exp Immunol; 1985 Jul; 61(1):31-8. PubMed ID: 3876181
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Loss of the CD5+ and CD45RAhi B cell subsets in alcoholics.
    Cook RT; Waldschmidt TJ; Cook BL; Labrecque DR; McLatchie K
    Clin Exp Immunol; 1996 Feb; 103(2):304-10. PubMed ID: 8565316
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analysis of the human VH gene repertoire. Differential effects of selection and somatic hypermutation on human peripheral CD5(+)/IgM+ and CD5(-)/IgM+ B cells.
    Brezinschek HP; Foster SJ; Brezinschek RI; Dörner T; Domiati-Saad R; Lipsky PE
    J Clin Invest; 1997 May; 99(10):2488-501. PubMed ID: 9153293
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Soluble costimulatory factors sCD28, sCD80, sCD86 and sCD152 in relation to other markers of immune activation in patients with myasthenia gravis.
    Kakoulidou M; Wang X; Zhao X; Pirskanen R; Lefvert AK
    J Neuroimmunol; 2007 Apr; 185(1-2):150-61. PubMed ID: 17346804
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased numbers of CD5+ B lymphocytes in schizophrenic patients.
    McAllister CG; Rapaport MH; Pickar D; Podruchny TA; Christison G; Alphs LD; Paul SM
    Arch Gen Psychiatry; 1989 Oct; 46(10):890-4. PubMed ID: 2478093
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [A case of refractory generalized myasthenia gravis with anti-acetylcholine receptor antibodies treated with rituximab].
    Hayashi R; Tahara M; Oeda T; Konishi T; Sawada H
    Rinsho Shinkeigaku; 2015; 55(4):227-32. PubMed ID: 25904250
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Myasthenia gravis: selective enrichment of antiacetylcholine receptor antibody production in untransformed human B cell cultures.
    Padberg F; Matsuda M; Fenk R; Patenge N; Kubuschok B; Hohlfeld R; Wekerle H; Spuler S
    Eur J Immunol; 1999 Nov; 29(11):3538-48. PubMed ID: 10556808
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia.
    Sthoeger ZM; Wakai M; Tse DB; Vinciguerra VP; Allen SL; Budman DR; Lichtman SM; Schulman P; Weiselberg LR; Chiorazzi N
    J Exp Med; 1989 Jan; 169(1):255-68. PubMed ID: 2462608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.